Serono reports earnings

Serono (SWX:SEO; SRA) reported first quarter earnings per ADS of $0.16, missing by $0.05 the Street's $0.21 estimate and down 6% from $0.17 in the same period last year. This quarter's figure excludes an exceptional charge of $725 million related to a U.S. Attorney's Office investigation regarding Serostim to treat AIDS wasting and cachexia (see BioCentury Extra, Thursday May 9, 2002). ...